Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 6
Results: 20
Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03695-5
- By:
- Publication type:
- Article
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03703-8
- By:
- Publication type:
- Article
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03704-7
- By:
- Publication type:
- Article
New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03684-8
- By:
- Publication type:
- Article
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03675-9
- By:
- Publication type:
- Article
Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03686-6
- By:
- Publication type:
- Article
Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03676-8
- By:
- Publication type:
- Article
A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03689-3
- By:
- Publication type:
- Article
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
- By:
- Publication type:
- Article
A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03680-y
- By:
- Publication type:
- Article
Correction to: Dominant‑negative transforming growth factor‑β receptor‑armoured mesothelin‑targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03693-7
- By:
- Publication type:
- Article
Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03691-9
- By:
- Publication type:
- Article
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03688-4
- By:
- Publication type:
- Article
TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8<sup>+</sup> T cell priming.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03679-5
- By:
- Publication type:
- Article
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03661-1
- By:
- Publication type:
- Article
T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03687-5
- By:
- Publication type:
- Article
Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03685-7
- By:
- Publication type:
- Article
Integrating bulk and single-cell sequencing data to construct a Scissor<sup>+</sup> dendritic cells prognostic model for predicting prognosis and immune responses in ESCC.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03683-9
- By:
- Publication type:
- Article
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03678-6
- By:
- Publication type:
- Article